|
| Status |
Public on Apr 11, 2006 |
| Title |
Treatment: RTI-6413-018; time: 24 hrs; repeat: 1 |
| Sample type |
RNA |
| |
|
| Source name |
LNCaP cells
|
| Organism |
Homo sapiens |
| Characteristics |
LNCaP cells; Human, prostate carcinoma, metastasized to lymph node; Maintained in DMEM/8% charcoal-stripped serum for 3 days before treatment.
|
| Treatment protocol |
In this experiment LNCaP cells
were treated with Vehicle (ethanol),
DHT (10 nM) or RTI-6413-018 (100 nM).
Treatment was done for 6 and 24 hrs.
The entire experiment was repeated 3 times.
|
| Extracted molecule |
polyA RNA |
| Label |
Biotin
|
| |
|
| Description |
A study of the SARM-regulated gene expression in LNCaP prostate carcinoma cells.
SARM-treated for 6 hrs
|
| Data processing |
Standard Affymetrix scanning/normalization process
|
| |
|
| Submission date |
Jul 19, 2005 |
| Last update date |
Apr 10, 2006 |
| Contact name |
Dmitri A Kazmin |
| E-mail(s) |
[email protected]
|
| Organization name |
Stanford University
|
| Department |
Institute for Immunity, Transplantation and Infection
|
| Lab |
Bali Pulendran
|
| Street address |
240 Pasteur Dr
|
| City |
Palo Alto |
| State/province |
CA |
| ZIP/Postal code |
94304 |
| Country |
USA |
| |
|
| Platform ID |
GPL96 |
| Series (1) |
| GSE4636 |
Differential redulation of gene expression by an RTI SARM and canonical agonist of androgen receptor |
|
